Kenneth W. Culver

Positive Impact — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

35h-index9.4kcitations108works0.22yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Virus-based gene therapy research(34), Lung Cancer Treatments and Mutations(23), RNA Interference and Gene Delivery(16), CRISPR and Genetic Engineering(14), Herpesvirus Infections and Treatments(11)

Publications107 total

P2.15.05 A Shared Decision Aid for First-Line Treatments of ALK+ Advanced Non-Small Cell Lung Cancer: A Patient-Centered Approach
Journal of Thoracic Oncology·2025
The role of pets in human and social service provisions: A panoramic view
Human-Animal Interactions·2025Open Access
Evaluating Diagnostic and Treatment Timelines for ALK-Positive NSCLC Patients: Results From a Global Registry
Clinical Lung Cancer·2025Open Access
Patient and caregiver treatment preferences for ALK+ non-small cell lung cancer in the United States.
Journal of Clinical Oncology·2025· 1 cited
Evaluating Diagnostic and Treatment Timelines for Alk-Positive Nsclc Patients: Results from a Global Registry
SSRN Electronic Journal·2025Open Access
Supplementary Tables 1-3 from Histone Deacetylase Inhibitor Panobinostat Induces Clinical Responses with Associated Alterations in Gene Expression Profiles in Cutaneous T-Cell Lymphoma
2023Open Access
Data from Histone Deacetylase Inhibitor Panobinostat Induces Clinical Responses with Associated Alterations in Gene Expression Profiles in Cutaneous T-Cell Lymphoma
2023Open Access
Supplementary Tables 1-3 from Histone Deacetylase Inhibitor Panobinostat Induces Clinical Responses with Associated Alterations in Gene Expression Profiles in Cutaneous T-Cell Lymphoma
2023Open Access
Data from Histone Deacetylase Inhibitor Panobinostat Induces Clinical Responses with Associated Alterations in Gene Expression Profiles in Cutaneous T-Cell Lymphoma
2023Open Access
Qualitative patient interviews on symptoms and impacts in metastatic synovial sarcoma (mSS).
Journal of Clinical Oncology·2020· 1 cited
Economic Impact of Next-Generation Sequencing Versus Single-Gene Testing to Detect Genomic Alterations in Metastatic Non–Small-Cell Lung Cancer Using a Decision Analytic Model
JCO Precision Oncology·2019· 220 cited
Real-world treatment patterns and survival of BRAF V600-mutated metastatic non-small cell lung cancer patients.
Journal of Clinical Oncology·2018
Economic impact of next generation sequencing vs sequential single-gene testing modalities to detect genomic alterations in metastatic non-small cell lung cancer using a decision analytic model.
Journal of Clinical Oncology·2018· 43 cited
Economic analysis of BRAF gene mutation testing in real world practice using claims data: costs of single gene versus panel tests in patients with lung cancer
Journal of Medical Economics·2018· 24 cited
Reimbursement landscape for molecular testing in non-small cell lung cancer (NSCLC).
PubMed·2018· 8 cited
Gene Therapy for Brain Tumors
2018· 1 cited
Treatment patterns, clinical and economic outcomes of patients with anaplastic lymphoma kinase-positive non-small cell lung cancer receiving ceritinib: a retrospective observational claims analysis
Journal of Drug Assessment·2018· 9 citedOpen Access
Budget Impact Analysis of First-Line Ceritinib in The Treatment of Alk+ Metastatic Non-Small Cell Lung Cancer (NSCLC) in The United States
Value in Health·2017
Monitoring for and Characterizing Crizotinib Progression: A Chart Review of ALK-Positive Non-Small Cell Lung Cancer Patients
Advances in Therapy·2017· 6 cited
Cognitive technology addressing optimal cancer clinical trial matching and protocol feasibility in a community cancer practice.
Journal of Clinical Oncology·2017· 9 cited
page 1 of 6Next →

Frequent Co-authors

R. Michael Blaese(21), W. French Anderson(9), Zvi Ram(8), Edward H. Oldfield(7), Annie Guérin(6), Medha Sasané(6), Kenneth Cornetta(5), A. Dusty Miller(4), Richard A. Morgan(4), Stuart Walbridge(4), Alexander R. Macalalad(4), Thomas A. Fleisher(3), Steven A. Rosenberg(3), Craig A. Mullen(3), Paul Aebersold(3), Michael T. Lotze(3), W. French Anderson(3), Daniel J. George(3), Monica Mita(3), Margaret Dugan(3)